Fractyl Health (GUTS) Total Non-Current Liabilities (2023 - 2026)
Fractyl Health (GUTS) recorded quarterly Total Non-Current Liabilities of $83.1 million in Q2 2026, up 7.35% on a QoQ basis from $77.4 million in Q1 2026, and up 4.73% YoY from $79.4 million in Q2 2025.
Analysis
Fractyl Health (GUTS) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has reported Total Non-Current Liabilities for 4 consecutive years, with $83.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities rose 4.73% year-over-year to $83.1 million; the trailing twelve-month figure through Jun 2026 stood at $83.1 million (up 4.73% YoY), and the FY2025 full-year result was $111.3 million, up 41.48% from the prior year.
- Total Non-Current Liabilities was $83.1 million for Q2 2026 at Fractyl Health, up from $77.4 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $304.6 million in Q3 2023, with the low at $74.7 million in Q2 2024.
- Historically, Total Non-Current Liabilities has averaged $105.1 million across 4 years, with a median of $79.0 million in 2024.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities sank 75.2% — and 2025, when it jumped 54.5%.
- Tracing GUTS's Total Non-Current Liabilities over 4 years: stood at $304.6 million in 2023, then sank by 74.18% to $78.7 million in 2024, then jumped by 41.48% to $111.3 million in 2025, then decreased by 25.3% to $83.1 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $83.1 million in Q2 2026, $77.4 million in Q1 2026, and $111.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Fractyl Health | 102.00 Mn | 102.00 Mn | - | 83.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.13 Mn |
| Mar 31, 2026 | 77.44 Mn |
| Dec 31, 2025 | 111.28 Mn |
| Sep 30, 2025 | 116.70 Mn |
| Jun 30, 2025 | 79.38 Mn |
| Mar 31, 2025 | 75.75 Mn |
| Dec 31, 2024 | 78.66 Mn |
| Sep 30, 2024 | 75.53 Mn |
| Jun 30, 2024 | 74.72 Mn |
| Mar 31, 2024 | 79.01 Mn |
| Sep 30, 2023 | 304.58 Mn |